Actuate Therapeutics Files 8-K
Ticker: ACTU · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-event, filing
TL;DR
Actuate Therapeutics filed an 8-K on 5/31, check for updates.
AI Summary
Actuate Therapeutics, Inc. filed an 8-K on June 2, 2025, reporting events as of May 31, 2025. The filing includes a Regulation FD Disclosure and Other Events, along with financial statements and exhibits. The company, formerly known as Apotheca Therapeutics, Inc., is incorporated in Delaware and based in Fort Worth, Texas.
Why It Matters
This 8-K filing provides updates on corporate events and financial information for Actuate Therapeutics, Inc., which is crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing with no immediate indication of significant financial distress or major operational changes.
Key Players & Entities
- Actuate Therapeutics, Inc. (company) — Registrant
- Apotheca Therapeutics, Inc. (company) — Former company name
- May 31, 2025 (date) — Earliest event date
- June 2, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Fort Worth, Texas (location) — Principal executive offices
FAQ
What specific events are disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What other events are reported in this 8-K?
The filing lists 'Other Events' as a category, but the specific nature of these events is not detailed in the provided text.
When was Actuate Therapeutics, Inc. formerly known as Apotheca Therapeutics, Inc.?
The company changed its name from Apotheca Therapeutics, Inc. on September 11, 2015.
What is the principal executive office address for Actuate Therapeutics, Inc.?
The principal executive offices are located at 1751 River Run, Suite 400, Fort Worth, Texas 76107.
What is the fiscal year end for Actuate Therapeutics, Inc.?
The fiscal year end for Actuate Therapeutics, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).